These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human natural killer T cells (NKT), NK and T cells in pulmonary tuberculosis: potential indicators for disease activity and prognosis. Zahran WA; Ghonaim MM; Koura BA; El-Banna H; Ali SM; El-Sheikh N Egypt J Immunol; 2006; 13(1):67-78. PubMed ID: 17974151 [TBL] [Abstract][Full Text] [Related]
8. Natural killer cell activity in patients with pulmonary tuberculosis and in healthy controls. Restrepo LM; Barrera LF; Garcia LF Tubercle; 1990 Jun; 71(2):95-102. PubMed ID: 2120829 [TBL] [Abstract][Full Text] [Related]
9. [The changes and the significance of cellular immune function in peripheral blood of patients with multidrug-resistant and extensively drug-resistant pulmonary tuberculosis]. Yang Y; Tang SJ; Zhang Q; Sun H; Liu YD; Hao XH; Yao L; Gu J Zhonghua Jie He He Hu Xi Za Zhi; 2011 Feb; 34(2):109-13. PubMed ID: 21426728 [TBL] [Abstract][Full Text] [Related]
10. [NK cell activity and counts of T-lymphocyte subsets in pulmonary tuberculosis]. Qin J Zhonghua Jie He He Hu Xi Za Zhi; 1990 Aug; 13(4):209-11, 254. PubMed ID: 2151030 [TBL] [Abstract][Full Text] [Related]
11. [Commemorative lecture of receiving Imamura Memorial Prize. NK cell in pulmonary tuberculosis from basic and clinical point of view]. Yoneda T Kekkaku; 1996 Nov; 71(11):625-31. PubMed ID: 8958676 [TBL] [Abstract][Full Text] [Related]
12. Elevated Natural Killer Cell-Mediated Cytotoxicity Is Associated with Cavity Formation in Pulmonary Tuberculosis Patients. Li S; Wang D; Wei P; Liu R; Guo J; Yang B; Zhang H; Lu J; Gao M; Pang Y J Immunol Res; 2021; 2021():7925903. PubMed ID: 34646890 [TBL] [Abstract][Full Text] [Related]
13. The presence of CD5LOW+NK cells in normal controls and patients with pulmonary tuberculosis. Ishiyama T; Watanabe K; Fukuchi K; Yajima K; Koike M; Tomoyasu S; Tsuruoka N Immunol Lett; 1993 Aug; 37(2-3):139-44. PubMed ID: 7505001 [TBL] [Abstract][Full Text] [Related]
14. [NK cells in patients during complex therapy of destructive pulmonary tuberculosis]. Gogebashvili NV; Nonikashvili MI Probl Tuberk; 1989; (4):43-5. PubMed ID: 2734264 [TBL] [Abstract][Full Text] [Related]
15. Augumentation of natural killer activity with exogenous interleukins in patients with HIV and pulmonary tuberculosis coinfection. Ramana Rao PV; Rajasekaran S; Raja A AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1435-43. PubMed ID: 19000024 [TBL] [Abstract][Full Text] [Related]
16. [Natural killer cells in middle-aged and elderly tuberculosis patients]. Adambekov DA Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):18-21. PubMed ID: 7778367 [TBL] [Abstract][Full Text] [Related]
17. [Analysis of NK cell activity in patient with pulmonary tuberculosis]. Shi R Zhonghua Jie He He Hu Xi Za Zhi; 1990 Dec; 13(6):363-4, 382. PubMed ID: 2085866 [TBL] [Abstract][Full Text] [Related]
18. NK cell activity in tuberculosis is associated with impaired CD11a and ICAM-1 expression: a regulatory role of monocytes in NK activation. Schierloh P; Alemán M; Yokobori N; Alves L; Roldán N; Abbate E; del C Sasiain M; de la Barrera S Immunology; 2005 Dec; 116(4):541-52. PubMed ID: 16313368 [TBL] [Abstract][Full Text] [Related]